Heavy Metals and Neurodegenerative Diseases: An Observational Study

Biological Trace Element Research

Volumn 161, Issue 2, 2014, Pages 151-160

  Giacoppo, Sabrina ^a   Galuppo, Maria ^a   Calabrò, Rocco Salvatore ^a   D’Aleo, Giangaetano ^a   Marra, Angela ^a   Sessa, Edoardo ^a   Bua, Daniel Giuseppe ^b   Potortì, Angela Giorgia ^b   Dugo, Giacomo ^b   Bramanti, Placido ^a   Mazzon, Emanuela ^a  

^a IRCCS CENTRO NEUROLESI BONINO PULEJO   (Italy)

^b UNIVERSITY OF MESSINA   (Italy)

Author keywords

Alzheimer s disease; Copper, zinc superoxide dismutase enzyme (Cu Zn SOD); Heavy metals; Inductively coupled plasma mass spectrometry (ICP MS); Multiple Sclerosis

Indexed keywords

COPPER; LEAD; MERCURY; SELENIUM; ZINC; HEAVY METAL;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BLOOD SAMPLING; COMPARATIVE STUDY; CONTROLLED STUDY; COPPER BLOOD LEVEL; DEGENERATIVE DISEASE; DIETARY INTAKE; DISEASE ASSOCIATION; DUST; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; FEMALE; FISH; FRUIT; FUME; HEAVY METAL BLOOD LEVEL; HUMAN; ITALY; LEAD BLOOD LEVEL; LIMIT OF DETECTION; LIMIT OF QUANTITATION; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; MEASUREMENT ACCURACY; MERCURY BLOOD LEVEL; MIDDLE AGED; MULTIPLE SCLEROSIS; OBSERVATIONAL STUDY; OXIDATIVE STRESS; QUANTITATIVE ANALYSIS; RISK FACTOR; SELENIUM BLOOD LEVEL; VEGETABLE; VERY ELDERLY; VOLCANO; ZINC BLOOD LEVEL; ADVERSE EFFECTS; BLOOD;

ADULT; AGED; ALZHEIMER DISEASE; ENVIRONMENTAL EXPOSURE; FEMALE; HUMANS; MALE; METALS, HEAVY; MIDDLE AGED; MULTIPLE SCLEROSIS; SICILY; VOLCANIC ERUPTIONS;

EID: 84911004269     PISSN: 01634984     EISSN: 15590720     Source Type: Journal    
DOI: 10.1007/s12011-014-0094-5     Document Type: Article

References (40)

1. Cannon JR, Greenamyre JT (2011) The role of environmental exposures in neurodegeneration and neurodegenerative diseases. Toxicol Sci 124:225–250. doi:10.1093/toxsci/kfr239
2. Yesavage JA, O’Hara R, Kraemer H, Noda A, Taylor JL, Ferris S, Gely-Nargeot MC, Rosen A, Friedman L, Sheikh J, Derouesne C (2002) Modeling the prevalence and incidence of Alzheimer’s disease and mild cognitive impairment. J Psychiatr Res 36:281–286
3. Tiraboschi P, Hansen LA, Thal LJ, Corey-Bloom J (2004) The importance of neuritic plaques and tangles to the development and evolution of AD. Neurology 62:1984–1989
4. Jellinger KA (2006) Alzheimer 100–highlights in the history of Alzheimer research. J Neural Transm 113:1603–1623. doi:10.1007/s00702-006-0578-3
5. Compston A, Coles A (2008) Multiple sclerosis. Lancet 372:1502–1517. doi:10.1016/S0140-6736(08)61620-7
6. Marik C, Felts PA, Bauer J, Lassmann H, Smith KJ (2007) Lesion genesis in a subset of patients with multiple sclerosis: a role for innate immunity? Brain 130:2800–2815. doi:10.1093/brain/awm236
7. Marras C, Goldman SM (2011) Genetics meets environment: Evaluating gene-environment interactions in neurologic diseases. Semin Neurol 31:553–561. doi:10.1055/s-0031-1299793
8. Briner W (2012) The role of metal regulatory proteins in brain oxidative stress: a tutorial. Oxid Med Cell Longev 2012:981561. doi:10.1155/2012/981561
9. Bowman AB, Kwakye GF, Herrero Hernandez E, Aschner M (2011) Role of manganese in neurodegenerative diseases. J Trace Elem Med Biol 25:191–203. doi:10.1016/j.jtemb.2011.08.144
10. Lo Turco V, Di Bella G, Furci P, Cicero N, Pollicino G, Dugo G (2013) Heavy metals content by ICP-OES in Sarda sarda, Sardinella aurita and Lepidopus caudatus from the Strait of Messina (Sicily, Italy). Nat Prod Res 27:518–523. doi:10.1080/14786419.2012.673611
11. Potorti’ AG, Di Bella G, Lo Turco V, Rando R, Dugo G (2013) Non-toxic and potentially toxic elements in Italian donkey milk by ICP-MS and multivariate analysis. J Food Compos Anal 31:161–172
12. Bonda DJ, Lee HG, Blair JA, Zhu X, Perry G, Smith MA (2011) Role of metal dyshomeostasis in Alzheimer’s disease. Metallomics 3:267–270. doi:10.1039/c0mt00074d
13. Sayre LM, Perry G, Harris PL, Liu Y, Schubert KA, Smith MA (2000) In situ oxidative catalysis by neurofibrillary tangles and senile plaques in Alzheimer’s disease: a central role for bound transition metals. J Neurochem 74:270–279
14. Brewer GJ, Kanzer SH, Zimmerman EA, Celmins DF, Heckman SM, Dick R (2010) Copper and ceruloplasmin abnormalities in Alzheimer’s disease. Am J Alzheimers Dis Other Demen 25:490–497. doi:10.1177/1533317510375083
15. Talmard C, Leuma Yona R, Faller P (2009) Mechanism of zinc(II)-promoted amyloid formation: zinc(II) binding facilitates the transition from the partially alpha-helical conformer to aggregates of amyloid beta protein(1-28). J Biol Inorg Chem 14:449–455. doi:10.1007/s00775-008-0461-9
16. Craddock TJ, Tuszynski JA, Chopra D, Casey N, Goldstein LE, Hameroff SR, Tanzi RE (2012) The zinc dyshomeostasis hypothesis of Alzheimer’s disease. PLoS One 7:e33552. doi:10.1371/journal.pone.0033552
17. Brewer GJ, Kanzer SH, Zimmerman EA, Molho ES, Celmins DF, Heckman SM, Dick R (2010) Subclinical zinc deficiency in Alzheimer’s disease and Parkinson’s disease. Am J Alzheimers Dis Other Demen 25:572–575. doi:10.1177/1533317510382283
18. Nunez MT, Urrutia P, Mena N, Aguirre P, Tapia V, Salazar J (2012) Iron toxicity in neurodegeneration. Biometals 25:761–776. doi:10.1007/s10534-012-9523-0
19. Rossi L, Lombardo MF, Ciriolo MR, Rotilio G (2004) Mitochondrial dysfunction in neurodegenerative diseases associated with copper imbalance. Neurochem Res 29:493–504
20. Greenough MA, Camakaris J, Bush AI (2013) Metal dyshomeostasis and oxidative stress in Alzheimer’s disease. Neurochem Int 62:540–555. doi:10.1016/j.neuint.2012.08.014
21. Ward RJ, Dexter DT, Crichton RR (2012) Chelating agents for neurodegenerative diseases. Curr Med Chem 19:2760–2772
22. Rossi L, Ciriolo MR, Marchese E, De Martino A, Giorgi M, Rotilio G (1994) Differential decrease of copper content and of copper binding to superoxide dismutase in liver, heart and brain of copper-deficient rats. Biochem Biophys Res Commun 203:1028–1034
23. Sedighi B, Ebrahimi HA, Haghdoost AA, Abotorabi M (2013) Comparison of serum levels of copper and zinc among multiple sclerosis patients and control group. Iran J Neurol 12:125–128
24. Wagner S, Breyholz HJ, Faust A, Holtke C, Levkau B, Schober O, Schafers M, Kopka K (2006) Molecular imaging of matrix metalloproteinases in vivo using small molecule inhibitors for SPECT and PET. Curr Med Chem 13:2819–2838
25. Jaiser SR, Winston GP (2010) Copper deficiency myelopathy. J Neurol 257:869–881. doi:10.1007/s00415-010-5511-x
26. Berr C, Balansard B, Arnaud J, Roussel AM, Alperovitch A (2000) Cognitive decline is associated with systemic oxidative stress: the EVA study. J Am Geriatr Soc 48:1285–1291
27. Papp LV, Lu J, Holmgren A, Khanna KK (2007) From selenium to selenoproteins: Synthesis, identity, and their role in human health. Antioxid Redox Signal 9:775–806. doi:10.1089/ars.2007.1528
28. Smorgon C, Mari E, Atti AR, Dalla Nora E, Zamboni PF, Calzoni F, Passaro A, Fellin R (2004) Trace elements and cognitive impairment: an elderly cohort study. Arch Gerontol Geriatr Suppl 393–402. doi:10.1016/j.archger.2004.04.050
29. Attar AM, Kharkhaneh A, Etemadifar M, Keyhanian K, Davoudi V, Saadatnia M (2012) Serum mercury level and multiple sclerosis. Biol Trace Elem Res 146:150–153. doi:10.1007/s12011-011-9239-y
30. Tsai CP, Lee CT (2013) Multiple sclerosis incidence associated with the soil lead and arsenic concentrations in Taiwan. PLoS One 8:e65911. doi:10.1371/journal.pone.0065911
31. Myers GJ, Davidson PW, Cox C, Shamlaye CF, Palumbo D, Cernichiari E, Sloane-Reeves J, Wilding GE, Kost J, Huang LS, Clarkson TW (2003) Prenatal methylmercury exposure from ocean fish consumption in the Seychelles child development study. Lancet 361:1686–1692. doi:10.1016/S0140-6736(03)13371-5
32. Leong CC, Syed NI, Lorscheider FL (2001) Retrograde degeneration of neurite membrane structural integrity of nerve growth cones following in vitro exposure to mercury. Neuroreport 12:733–737
33. Olivieri G, Novakovic M, Savaskan E, Meier F, Baysang G, Brockhaus M, Muller-Spahn F (2002) The effects of beta-estradiol on SHSY5Y neuroblastoma cells during heavy metal induced oxidative stress, neurotoxicity and beta-amyloid secretion. Neuroscience 113:849–855
34. Bjorkman L, Lundekvam BF, Laegreid T, Bertelsen BI, Morild I, Lilleng P, Lind B, Palm B, Vahter M (2007) Mercury in human brain, blood, muscle and toenails in relation to exposure: an autopsy study. Environ Health 6:30. doi:10.1186/1476-069X-6-30
35. Lee JY, Kim JH, Choi DW, Lee DW, Park JH, Yoon HJ, Pyo HS, Kwon HJ, Park KS (2012) The association of heavy metal of blood and serum in the Alzheimer’s diseases. Toxicol Res 28:93–98. doi:10.5487/TR.2012.28.2.093
36. Fung YK, Meade AG, Rack EP, Blotcky AJ, Claassen JP, Beatty MW, Durham T (1995) Determination of blood mercury concentrations in Alzheimer’s patients. Am J Epidemiol 33:243–247
37. Aminzadeh KK, Etminan M (2007) Dental amalgam and multiple sclerosis: a systematic review and meta-analysis. J Public Health Dent 67:64–66
38. Khalil N, Morrow LA, Needleman H, Talbott EO, Wilson JW, Cauley JA (2009) Association of cumulative lead and neurocognitive function in an occupational cohort. Neuropsychology 23:10–19. doi:10.1037/a0013757
39. Yun SW, Hoyer S (2000) Effects of low-level lead on glycolytic enzymes and pyruvate dehydrogenase of rat brain in vitro: relevance to sporadic Alzheimer’s disease? J Neural Transm 107:355–368
40. Ewers M, Walsh C, Trojanowski JQ, Shaw LM, Petersen RC, Jack CR Jr, Feldman HH, Bokde AL, Alexander GE, Scheltens P, Vellas B, Dubois B, Weiner M, Hampel H (2012) Prediction of conversion from mild cognitive impairment to Alzheimer’s disease dementia based upon biomarkers and neuropsychological test performance. Neurobiol Aging 33:1203–1214. doi:10.1016/j.neurobiolaging.2010.10.019